Streetinsider

Published October 7, 2026

Clearmind submits psychedelic therapy recommendations to FDA - StreetInsider

Read the full story at Streetinsider

psychedelic drugs, according to a press release. The submission, filed under FDA Docket No. FDA-2026-N-7542, focuses on non-hallucinogenic psychedelic.